Key Insights

Highlights

Treatment Research

2 treatments under study, led by Zoledronic Acid Injectable Product

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown1
Terminated1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06024798UnknownPrimary

Detecting and Assessing Leg and Foot Stress Fractures Using Photon Counting CT

NCT03576599Phase 4TerminatedPrimary

Intravenous Bisphosphonate in Stress Fracture Treatment -A Randomised Controlled Double Blinded Multicenter Trial

Showing all 2 trials

Research Network

Common Treatments

  • Zoledronic Acid Injectable Product1
  • Photoncountingcomputedtomography1

Active Sponsors

  • Betanien Hospital1
  • Balgrist University Hospital1
  • Sykehuset Ostfold1
  • Oslo University Hospital1

Top Investigators

Related Conditions

  • Stress Fracture Ankle2
  • Stress Fracture Metatarsal1
  • Lower Limb Fracture1
  • Stress Fracture Of Tibia1

Activity Timeline